Efficient non-viral delivery of macromolecules in human primary hematopoietic stem cells and lymphocytes.

J Mol Cell Biol

Department of Rheumatology and Immunology, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China.

Published: August 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481097PMC
http://dx.doi.org/10.1093/jmcb/mjad018DOI Listing

Publication Analysis

Top Keywords

efficient non-viral
4
non-viral delivery
4
delivery macromolecules
4
macromolecules human
4
human primary
4
primary hematopoietic
4
hematopoietic stem
4
stem cells
4
cells lymphocytes
4
efficient
1

Similar Publications

Enhanced mRNA and pDNA delivery PEGylated solid lipid nanoparticles with an optimally balanced ionizable/cationic lipid content.

J Mater Chem B

September 2025

Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, Centros #06-01, Singapore 138668, Republic of Singapore.

Non-viral gene delivery holds significant promise for the treatment of various diseases. Solid lipid nanoparticles (SLNs) are emerging as promising gene delivery vehicles due to their ease of manufacture and high stability. However, the development of efficient and safe SLNs remains a challenge.

View Article and Find Full Text PDF

Adipocyte-selective mRNA lipid nanoparticles for cell programming with machine learning analysis.

J Control Release

August 2025

Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD, USA; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department

Adipose tissue plays a crucial role in energy metabolism and endocrine signaling. White adipose tissue (WAT), in particular, is a compelling target for therapeutic interventions in metabolic diseases due to its secretory capacity and abundance. Gene therapies hold promise for reprogramming adipocytes to enhance energy metabolism and facilitate the secretion of therapeutic proteins.

View Article and Find Full Text PDF

Gene therapy offers a transformative approach for treating debilitating bone disorders by delivering therapeutic genetic material to target sites. The efficacy and safety of this approach are heavily reliant on the chosen delivery vehicle, either viral or non-viral vectors. Viral vectors are characterized by high transduction efficiency and the potential for long-term expression, as exemplified by Adeno-Associated Viruses (AAVs) and lentiviruses.

View Article and Find Full Text PDF

Efficient nucleic acid delivery into target cells remains a critical challenge in gene therapy. Due to its advantages in biocompatibility and safety, recent research has increasingly focused on non-viral gene delivery. .

View Article and Find Full Text PDF